Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Dollar change -0.10
Percentage change -3.98	%

Peers: REGN BMRN SRPT ASND CRSP FATE NTLA EDIT BLUE LBPH

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	35.74%	Shs Outstand	26.04M	Perf Week	4.33%
Market Cap	130.52M	Forward P/E	-	EPS next Y	-1.03	Insider Trans	-16.52%	Shs Float	20.75M	Perf Month	4.33%
Income	-30.58M	PEG	-	EPS next Q	-0.29	Inst Own	6.13%	Short Float	12.28%	Perf Quarter	1.60%
Sales	0.00M	P/S	-	EPS this Y	7.44%	Inst Trans	-4.40%	Short Ratio	1.60	Perf Half Y	-61.81%
Book/sh	0.11	P/B	22.52	EPS next Y	16.33%	ROA	-48.07%	Short Interest	2.55M	Perf Year	21.72%
Cash/sh	0.58	P/C	4.16	EPS next 5Y	-9.40%	ROE	-227.14%	52W Range	1.90 - 8.75	Perf YTD	-27.41%
Dividend Est.	-	P/FCF	-	EPS past 5Y	0.28%	ROI	-125.19%	52W High	-72.46%	Beta	0.15
Dividend TTM	-	Quick Ratio	1.93	Sales past 5Y	83.82%	Gross Margin	-	52W Low	26.84%	ATR (14)	0.25
Dividend Ex-Date	-	Current Ratio	1.93	EPS Y/Y TTM	14.27%	Oper. Margin	0.00%	RSI (14)	49.78	Volatility	7.82% 14.04%
Employees	140	Debt/Eq	12.46	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	12.00
Option/Short	Yes / Yes	LT Debt/Eq	7.63	EPS Q/Q	29.56%	Payout	-	Rel Volume	0.40	Prev Close	2.51
Sales Surprise	-	EPS Surprise	22.43%	Sales Q/Q	-	Earnings	Aug 06 AMC	Avg Volume	1.59M	Price	2.41
SMA20	-2.07%	SMA50	-0.34%	SMA200	-34.14%	Trades		Volume	631,274	Change	-3.98%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-02-24	Initiated	Oppenheimer	Outperform	$17
Jun-14-24	Initiated	Maxim Group	Buy	$15
Jun-13-24	Initiated	Rodman & Renshaw	Buy	$10
Apr-17-23	Resumed	BTIG Research	Buy	$24
Oct-11-22	Initiated	UBS	Buy	$15
Jul-27-22	Initiated	H.C. Wainwright	Buy	$22
Jun-13-22	Initiated	Wedbush	Outperform	$28

Nov-07-24 04:05PM	Rani Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-17-24 08:00AM	Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Oct-15-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants (GlobeNewswire) -33.33%
Oct-13-24 06:01AM	Oppenheimer Predicts up to 740% Rally for These 2 Strong Buy Stocks (TipRanks)
Oct-08-24 04:05PM	Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) +7.31%
04:05PM	Loading…
Sep-03-24 04:05PM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire) -7.50%
Aug-06-24 04:05PM	Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Jul-29-24 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jul-22-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering (GlobeNewswire)
Jun-24-24 07:00AM	Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment (GlobeNewswire)
May-16-24 10:15AM	UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating (MT Newswires)
May-14-24 08:00AM	Rani Therapeutics to Participate in May Investor Conferences (GlobeNewswire) -5.40%
May-09-24 08:00AM	Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill Capsule at Digestive Disease Week 2024 (GlobeNewswire) -5.17%
May-07-24 09:06PM	Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates (GuruFocus.com)
May-06-24 09:55PM	RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q1 2024 (InvestorPlace) +5.73%
04:05PM	Loading…
04:05PM	Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-21-24 09:45AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:35AM	Q4 2023 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-15-24 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) +6.25%
Feb-05-24 08:00AM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) (GlobeNewswire) +5.73%
Dec-14-23 08:00AM	Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Dec-07-23 12:00PM	What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock (Zacks)
Nov-08-23 05:53PM	Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments (GuruFocus.com)
04:05PM	Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-01-23 04:05PM	Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 08:00AM	The RaniPill Capsule, Rani Therapeutics' Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study (GlobeNewswire)
Oct-19-23 04:05PM	Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study (GlobeNewswire)
Oct-12-23 04:05PM	Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (GlobeNewswire)
Sep-18-23 08:00AM	Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43) (GlobeNewswire)
04:05PM	Loading…
Sep-07-23 04:05PM	Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies (GlobeNewswire)
Sep-06-23 08:00AM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire)
Aug-11-23 04:05PM	Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Aug-04-23 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jun-21-23 08:00AM	Rani Therapeutics Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference (GlobeNewswire)
Jun-08-23 08:00AM	Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference (GlobeNewswire)
Jun-05-23 08:00AM	Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105 (GlobeNewswire)
Jun-01-23 08:00AM	Rani Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-23 08:00AM	Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference (GlobeNewswire)
May-24-23 08:00AM	Rani Therapeutics Appoints Kate McKinley as Chief Business Officer (GlobeNewswire)
May-17-23 09:50AM	2 Strong Buy Penny Stocks With Over 400% Upside on the Horizon (TipRanks) +12.25%
May-10-23 04:05PM	Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire) -8.84%
Apr-26-23 06:46AM	Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) last week's 14% decline must have disappointed private companies who have a significant stake (Simply Wall St.)
Apr-25-23 08:00AM	Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-11-23 08:00AM	Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-23 07:12AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -6.89%
Mar-16-23 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire) +5.71%
Jan-09-23 08:30AM	Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment (GlobeNewswire)
Jan-05-23 04:05PM	Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update (GlobeNewswire) +8.12%
Dec-06-22 04:05PM	Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study (GlobeNewswire) +9.67%
Nov-17-22 05:30AM	Private companies among Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders, saw gain in holdings value after stock jumped 21% last week (Simply Wall St.)
Nov-10-22 05:25PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-09-22 04:05PM	Rani Therapeutics to Present at the Stifel Healthcare Conference (GlobeNewswire)
Oct-28-22 09:55AM	Here's Why Rani Therapeutics Holdings, Inc. (RANI) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Oct-24-22 08:30AM	Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update (GlobeNewswire) -10.03%
Sep-27-22 09:06AM	8 Best Stocks to Buy According to Billionaire Marc Lasry (Insider Monkey)
Sep-06-22 04:05PM	Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 11:47PM	Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock (GlobeNewswire) -25.89% +37.55%
Aug-10-22 05:45PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:28PM	Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock (GlobeNewswire)
04:28PM	Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
04:23PM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis (GlobeNewswire)
Aug-08-22 08:30AM	Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development (GlobeNewswire)
Aug-03-22 07:48AM	Investors in Rani Therapeutics Holdings (NASDAQ:RANI) have made a return of 16% over the past year (Simply Wall St.)
May-11-22 04:05PM	Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -5.75%
May-04-22 03:09PM	Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth (Simply Wall St.)
May-03-22 04:05PM	Rani Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) -6.19%
07:00AM	Rani Therapeutics RaniPill Capsule Named Winner in the Health Category of Fast Companys 2022 World Changing Ideas Awards (GlobeNewswire)
Apr-07-22 04:05PM	Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-22 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-23-22 08:38PM	Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022 (GlobeNewswire)
08:00AM	Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis (GlobeNewswire)
Feb-23-22 08:00AM	Rani Therapeutics Unveils High-Capacity RaniPill Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results (GlobeNewswire) -8.47%
Jan-19-22 04:30AM	5 Biotech Stocks That Are Bucking the Selloff (Barrons.com) +7.97%
Jan-07-22 08:00AM	Rani Therapeutics Appoints Lisa Rometty to Board of Directors (GlobeNewswire)
Dec-20-21 07:26PM	These are the top 10 best performing newly public Bay Area stocks (American City Business Journals)
Nov-15-21 07:31PM	Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire)
Nov-12-21 04:05PM	Rani Therapeutics Appoints Lyn Baranowski to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference (GlobeNewswire) +6.68%
Oct-08-21 12:42PM	Most of this year's flood of new Bay Area public companies are 'under water' (American City Business Journals) +13.29%
Oct-04-21 06:00AM	This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More (Motley Fool)
Sep-23-21 04:05PM	Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
Sep-13-21 04:05PM	Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire) +6.19% -9.15%
Sep-09-21 08:00AM	Rani Therapeutics Announces Appointment of Eric Groen as General Counsel (GlobeNewswire)
Aug-24-21 02:14PM	Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA (Benzinga)
Aug-13-21 04:05PM	Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire) +6.77% -16.82%
Jul-30-21 08:56AM	Rani Therapeutics Announces Pricing of Initial Public Offering (GlobeNewswire)

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
South Cone Investments Limited	10% Owner	Oct 15 '24	Sale	2.65	3,829,360	10,141,674	8,302,194	Oct 17 04:30 PM
Quiroga Cortes Isidoro Alfonso	10% Owner	Nov 24 '23	Sale	2.01	5,265,165	10,582,982	8,400	Dec 08 04:29 PM
South Cone Investments Limited	10% Owner	Nov 24 '23	Buy	2.01	5,265,165	10,582,982	12,131,554	Dec 08 04:27 PM
Imran Talat	Chief Executive Officer	Dec 06 '23	Buy	2.27	10,000	22,700	484,455	Dec 07 05:18 PM
Imran Talat	Chief Executive Officer	Dec 04 '23	Buy	2.57	5,000	12,850	474,455	Dec 06 08:00 AM
Imran Talat	Chief Executive Officer	Nov 29 '23	Buy	2.05	20,000	41,000	469,455	Dec 01 08:00 AM
BUTEL JEAN LUC	Director	Nov 17 '23	Buy	2.03	50,500	102,495	50,500	Nov 21 04:05 PM
Nanavaty Maulik	Director	Nov 16 '23	Buy	1.98	500	990	500	Nov 20 08:00 AM

Open in Screener

FTCI

FTC Solar Inc

Nov 08 • 04:00PM ET

0.4871

Dollar change -0.0170
Percentage change -3.37	%

Technology • Solar • USA • NASD

Peers: SEDG ENPH RUN CSIQ JKS FSLR MAXN ACA SHLS

| Held by: VTI VXF CCSO

Index	-	P/E	-	EPS (ttm)	-0.40	Insider Own	45.22%	Shs Outstand	125.45M	Perf Week	-13.44%
Market Cap	60.11M	Forward P/E	-	EPS next Y	-0.11	Insider Trans	4.39%	Shs Float	69.97M	Perf Month	7.65%
Income	-49.13M	PEG	-	EPS next Q	-0.09	Inst Own	14.90%	Short Float	8.17%	Perf Quarter	131.07%
Sales	77.77M	P/S	0.77	EPS this Y	3.39%	Inst Trans	-27.60%	Short Ratio	0.82	Perf Half Y	4.60%
Book/sh	0.35	P/B	1.40	EPS next Y	60.15%	ROA	-41.32%	Short Interest	5.71M	Perf Year	15.15%
Cash/sh	0.09	P/C	5.58	EPS next 5Y	-	ROE	-79.47%	52W Range	0.18 - 1.00	Perf YTD	-29.69%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-27.59%	ROI	-108.33%	52W High	-51.24%	Beta	1.76
Dividend TTM	-	Quick Ratio	1.14	Sales past 5Y	61.44%	Gross Margin	-0.49%	52W Low	177.08%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	1.64	EPS Y/Y TTM	38.92%	Oper. Margin	-67.43%	RSI (14)	43.23	Volatility	13.01% 12.19%
Employees	213	Debt/Eq	0.04	Sales Y/Y TTM	-32.99%	Profit Margin	-63.17%	Recom	1.80	Target Price	0.91
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	-4.98%	Payout	-	Rel Volume	0.15	Prev Close	0.50
Sales Surprise	-12.32%	EPS Surprise	-3.21%	Sales Q/Q	-64.68%	Earnings	Nov 12 BMO	Avg Volume	6.97M	Price	0.49
SMA20	-15.16%	SMA50	-1.32%	SMA200	5.99%	Trades		Volume	1,054,175	Change	-3.37%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-14-24	Downgrade	ROTH MKM	Buy → Neutral
Nov-09-23	Downgrade	Northland Capital	Outperform → Market Perform	$0.65
Aug-15-23	Downgrade	UBS	Buy → Neutral	$4 → $2.50
Apr-13-23	Initiated	H.C. Wainwright	Buy	$5
Mar-15-23	Upgrade	BofA Securities	Underperform → Buy	$2 → $3.50
Jul-19-22	Upgrade	Piper Sandler	Underweight → Neutral	$2 → $3.50
Jun-06-22	Upgrade	ROTH Capital	Neutral → Buy
May-23-22	Initiated	Northland Capital	Outperform	$7
Apr-21-22	Downgrade	Piper Sandler	Neutral → Underweight	$4 → $3
Apr-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4
Jan-24-22	Downgrade	ROTH Capital	Buy → Neutral	$15 → $4
Jan-14-22	Downgrade	BofA Securities	Neutral → Underperform	$9 → $5
Dec-14-21	Initiated	Colliers Securities	Buy	$13
Oct-20-21	Upgrade	Barclays	Equal Weight → Overweight	$11 → $9
Jun-10-21	Initiated	Piper Sandler	Overweight	$15
Jun-09-21	Downgrade	BofA Securities	Buy → Neutral
May-24-21	Initiated	UBS	Buy	$13
May-24-21	Initiated	ROTH Capital	Buy	$15
May-24-21	Initiated	Credit Suisse	Outperform	$23
May-24-21	Initiated	Cowen	Outperform	$13

Show Previous Ratings

Nov-05-24 08:29AM	FTC Solar to supply trackers for 1GW Dunlieh Energy solar projects (Power Technology)
08:02AM	FTC Solar to Announce Third Quarter Financial Results Tuesday, November 12, 2024 (GlobeNewswire)
Nov-04-24 08:30AM	FTC Solar Announces 1GW Tracker Supply Agreement with Dunlieh Energy (GlobeNewswire)
Oct-24-24 08:25AM	FTC Solar to supply 1GW of projects for Sandhills Energy (TipRanks) +7.61%
Oct-23-24 08:02AM	FTC Solar to Supply Approximately 1GW of Projects for Sandhills Energy (GlobeNewswire)
05:37PM	Loading…
Oct-09-24 05:37PM	FTC Solar Inc (FTCI) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com)
Oct-08-24 08:50AM	Fast-paced Momentum Stock FTC Solar (FTCI) Is Still Trading at a Bargain (Zacks) -6.31%
Sep-20-24 10:23AM	FTC Solar, Inc. (FTCI): A Bull Case Theory (Insider Monkey) -6.85%
Sep-10-24 04:01PM	FTC Solar Announces Multi-Year Tracker Supply Agreement with Strata Clean Energy (GlobeNewswire) +5.68% +104.00%
Aug-28-24 08:00AM	FTC Solar to Participate at RE+ Event September 9-12 (GlobeNewswire) -5.78%
Aug-16-24 04:58PM	FTC Solar Announces Inducement Grant of Employee Inducement Award (GlobeNewswire)
08:38AM	FTC Solar Appoints Pablo Barahona to Board of Directors (GlobeNewswire)
Aug-15-24 07:45AM	FTC Solar Announces Resignation of Board Member (GlobeNewswire) -5.55%
Aug-09-24 12:47AM	Q2 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-08-24 07:40AM	FTC Solar (FTCI) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -33.40%
06:38AM	Loading…
06:38AM	FTC Solar: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 04:01PM	FTC Solar to Announce Second Quarter Financial Results Thursday, August 8, 2024 (GlobeNewswire)
Jul-23-24 04:01PM	FTC Solar Appoints Yann Brandt as New CEO (GlobeNewswire) +6.97%
May-31-24 06:39PM	Is FTC Solar, Inc. (NASDAQ:FTCI) the Best Renewable Energy Penny Stock According to Hedge Funds? (Insider Monkey) +6.96%
06:29PM	10 Best Renewable Energy Penny Stocks to Invest In (Insider Monkey)
May-30-24 10:39AM	FTC Solar Introduces Automated Hail Stow Solution to Mitigate Solar Panel Damage (PR Newswire)
May-15-24 08:15AM	FTC Solar Announces New Sales and Leadership Appointments (GlobeNewswire)
May-13-24 10:35AM	Piper Sandler Trims FTC Solar Price Target to $0.40 From $0.50, Maintains Neutral Rating (MT Newswires) +7.04%
03:04AM	FTC Solar Inc (FTCI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-11-24 09:42AM	FTC Solar, Inc. (NASDAQ:FTCI) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:00AM	Q1 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-24 10:52AM	FTCI Stock Earnings: FTC Solar Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace) -15.33%
06:41AM	FTC Solar: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces First Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Loading…
May-06-24 04:01PM	FTC Solar to Announce First Quarter Financial Results Friday, May 10, 2024 (GlobeNewswire) +7.28%
May-01-24 10:01AM	Earnings Preview: FTC Solar (FTCI) Q1 Earnings Expected to Decline (Zacks)
Apr-11-24 01:33PM	7 Penny Stocks if You Believe Lady Lucks on Your Side (InvestorPlace)
Mar-27-24 08:28AM	Heliogen, Inc. (NYSE:HLGN) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.35%
Mar-16-24 02:17PM	FTC Solar, Inc. (NASDAQ:FTCI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-15-24 08:30AM	FTC Solar to Present at Roth Conference March 18, 2024 (GlobeNewswire)
Mar-13-24 05:15PM	FTC Solar (FTCI) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.28%
04:25PM	FTC Solar: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	FTC Solar Announces Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-27-24 08:00AM	FTC Solar to Announce Fourth Quarter and Full Year 2023 Financial Results Wednesday, March 13, 2024 (GlobeNewswire)
Feb-12-24 08:00AM	Cathy Behnen Appointed FTC Solar Chief Financial Officer (GlobeNewswire) +24.75%
Dec-21-23 09:26AM	5 Most Promising Solar Stocks According to Analysts (Insider Monkey)
Dec-07-23 08:00AM	FTC Solar Appoints Anthony Carroll as Chairman of Newly Formed Customer Advisory Board (GlobeNewswire)
Nov-09-23 04:25PM	FTC Solar, Inc. (NASDAQ:FTCI) Q3 2023 Earnings Call Transcript (Insider Monkey) +6.29%
Nov-08-23 06:43AM	FTC Solar: Q3 Earnings Snapshot (Associated Press Finance) -64.45%
06:30AM	FTC Solar Announces Third Quarter 2023 Financial Results and Leadership Transition (GlobeNewswire)
Oct-25-23 08:00AM	FTC Solar to Announce Third Quarter Financial Results Wednesday, November 8, 2023 (GlobeNewswire)
Oct-12-23 08:58AM	Strength Seen in Shoals Technologies (SHLS): Can Its 5.3% Jump Turn into More Strength? (Zacks) -5.76%
Oct-04-23 08:00AM	FTC Solar Awarded 225MW Sandhills Energy Solar Project (GlobeNewswire) -5.93%
Oct-03-23 08:00AM	FTC's Newly Released White Paper, Unveils the Game-Changing Benefits of a Proven Solution for Complex Subsurface Conditions (GlobeNewswire)
Sep-15-23 01:16PM	Director William Priddy Acquires 17,000 Shares of FTC Solar Inc (GuruFocus.com)
Sep-14-23 01:03PM	10% Owner Family Arc Sells 100,000 Shares of FTC Solar Inc (GuruFocus.com)
Aug-31-23 06:00AM	FTC Solar Unveils Tracker-Agnostic SUNOPS Software to Enhance Solar Plant Performance (Business Wire)
Aug-10-23 03:49PM	FTC Solar, Inc. (NASDAQ:FTCI) Analysts Just Slashed This Year's Estimates (Simply Wall St.)
Aug-09-23 07:50AM	FTC Solar (FTCI) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -33.53%
06:44AM	FTC Solar: Q2 Earnings Snapshot (AP Finance)
06:32AM	FTC Solar and Cat Creek Energy Announce 1-Gigawatt Tracker Agreement to Supply Landmark Renewables Project (GlobeNewswire)
06:31AM	FTC Solar Announces 300MW Tracker Agreement in Spain and Italy to Include Utility-Scale Agrivoltaic Projects (GlobeNewswire)
06:30AM	FTC Solar Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-07-23 07:15PM	Ranger Energy (RNGR) Q2 Earnings and Revenues Lag Estimates (Zacks)
Jul-28-23 08:05AM	FTC Solar to Announce Second Quarter Financial Results Wednesday, August 9, 2023 (GlobeNewswire)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
Jul-12-23 05:35PM	3 Stocks to Buy for The Continued Growth of Solar Energy (Zacks)
Jul-10-23 08:36AM	Despite recent sales, FTC Solar, Inc. (NASDAQ:FTCI) insiders still hold the largest share with a 37% interest (Simply Wall St.)
Jul-06-23 04:02PM	FTC Solar Appoints Tony Alvarez as Board Observer (GlobeNewswire)
Jun-12-23 07:39AM	FTC Solar, Inc. (NASDAQ:FTCI): Is Breakeven Near? (Simply Wall St.)
May-16-23 07:05AM	FTC Solar (NASDAQ:FTCI) rallies 29% this week, taking one-year gains to 15% (Simply Wall St.) -5.88%
May-11-23 12:57PM	FTC Solar, Inc. (NASDAQ:FTCI) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-10-23 07:45AM	FTC Solar (FTCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:38AM	FTC Solar: Q1 Earnings Snapshot (AP Finance)
06:30AM	FTC Solar Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-08-23 09:00AM	Want Better Returns? Don't Ignore These 2 Oils-Energy Stocks Set to Beat Earnings (Zacks)
May-03-23 10:00AM	FTC Solar (FTCI) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
May-01-23 09:40AM	Is First Solar (FSLR) Stock Outpacing Its Oils-Energy Peers This Year? (Zacks)
Apr-27-23 08:00AM	FTC Solar to Announce First Quarter Financial Results Wednesday, May 10, 2023 (GlobeNewswire) +5.45%
Apr-17-23 06:55AM	After Leaping 34% FTC Solar, Inc. (NASDAQ:FTCI) Shares Are Not Flying Under The Radar (Simply Wall St.)
Apr-13-23 09:40AM	Is FTC Solar (FTCI) Outperforming Other Oils-Energy Stocks This Year? (Zacks)
Apr-05-23 01:42PM	Recent gains in FTC Solar, Inc. (NASDAQ:FTCI) help add back some value on insider purchases worth US$2.1m, still down US$419k (Simply Wall St.)
Mar-16-23 06:50AM	Newsflash: FTC Solar, Inc. (NASDAQ:FTCI) Analysts Have Been Trimming Their Revenue Forecasts (Simply Wall St.) -6.20%
Mar-10-23 04:01PM	FTC Solar to Present at Roth Conference March 13, 2023 (GlobeNewswire) -6.62%
Mar-03-23 06:10AM	A Look At The Intrinsic Value Of FTC Solar, Inc. (NASDAQ:FTCI) (Simply Wall St.)
Mar-02-23 07:05AM	FTC Solar, Inc. (NASDAQ:FTCI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-01-23 02:03AM	Q4 2022 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents) -5.86%
Feb-28-23 08:05AM	FTC Solar (FTCI) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +8.87%
06:30AM	FTC Solar Announces Fourth Quarter 2022 Financial Results (GlobeNewswire)
Feb-21-23 10:00AM	FTC Solar (FTCI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) -7.53%
Feb-15-23 08:30AM	FTC Solar to Announce Fourth Quarter and Full Year 2022 Financial Results Tuesday, February 28, 2023 (GlobeNewswire) +7.19%
Feb-09-23 04:10PM	FTC Solar Announces Solar Tracker Manufacturing Joint Venture (GlobeNewswire)
Jan-31-23 06:17AM	Insiders of FTC Solar, Inc. (NASDAQ:FTCI) must be disappointed as stock fell 11% after recent purchases (Simply Wall St.)
Jan-23-23 08:00AM	FTC Solar Announces Board Transition (GlobeNewswire) +8.25%
Jan-09-23 04:02PM	FTC Solar to Present at Needham Growth Conference January 12, 2023 (GlobeNewswire) +8.17%
Dec-29-22 02:18PM	When Can We Expect A Profit From FTC Solar, Inc. (NASDAQ:FTCI)? (Simply Wall St.) +11.84%
Dec-02-22 01:45PM	The past year for FTC Solar (NASDAQ:FTCI) investors has not been profitable (Simply Wall St.) +7.02%
Nov-12-22 07:31AM	The Consensus EPS Estimates For FTC Solar, Inc. (NASDAQ:FTCI) Just Fell A Lot (Simply Wall St.)
Nov-11-22 05:25AM	FTC Solar Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.) -7.19%
Nov-09-22 07:55AM	FTC Solar (FTCI) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +12.95%
06:30AM	FTC Solar Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-08-22 04:04PM	FTC's Novel Clamping Solution for First Solar Modules Enables Rapid Installation (PR Newswire)
Nov-02-22 10:01AM	Earnings Preview: FTC Solar (FTCI) Q3 Earnings Expected to Decline (Zacks) -8.42%
Oct-27-22 07:14AM	Bullish insiders bet US$1.5m on FTC Solar, Inc. (NASDAQ:FTCI) (Simply Wall St.)

FTC Solar, Inc. provides solar tracker systems, technology, software, and engineering services. Solar trackers significantly increase energy production at solar power installations by dynamically optimizing solar panel orientation to the sun. The company was founded by David Springer and Ahmad R. Chatila in 2017 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chatila Ahmad R	Director	Sep 06 '24	Buy	0.21	238,000	49,980	1,951,046	Sep 09 08:00 AM
Chatila Ahmad R	Director	Sep 04 '24	Buy	0.23	110,000	25,300	1,713,046	Sep 05 08:00 AM
Chatila Ahmad R	Director	Aug 26 '24	Buy	0.25	100,000	25,000	1,603,046	Aug 27 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 19 '24	Buy	0.25	160,000	40,000	2,411,740	Aug 21 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 20 '24	Buy	0.26	30,000	7,800	2,441,740	Aug 21 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 16 '24	Buy	0.25	200,000	50,000	2,251,740	Aug 20 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 15 '24	Buy	0.24	106,048	25,452	2,051,740	Aug 20 08:00 AM
Chatila Ahmad R	Director	Aug 19 '24	Buy	0.25	100,000	25,000	1,503,046	Aug 20 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 14 '24	Buy	0.25	321,337	80,334	1,941,740	Aug 16 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 15 '24	Buy	0.26	3,952	1,028	1,945,692	Aug 16 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 12 '24	Buy	0.22	500,000	110,000	1,580,403	Aug 15 08:00 AM
Quiroga Cortes Isidoro Alfonso	Former Director	Aug 13 '24	Buy	0.22	40,000	8,800	1,620,403	Aug 15 08:00 AM
Chatila Ahmad R	Director	Aug 12 '24	Buy	0.23	212,800	48,944	1,403,046	Aug 13 08:30 AM
Chatila Ahmad R	Director	Jun 14 '24	Buy	0.45	108,062	48,628	1,190,246	Jun 18 09:00 AM
Chatila Ahmad R	Director	Jun 13 '24	Buy	0.44	114,726	50,479	1,082,184	Jun 14 08:44 AM
Chatila Ahmad R	Director	Mar 26 '24	Buy	0.51	97,400	49,674	967,458	Mar 27 08:30 AM
Chatila Ahmad R	Director	Mar 22 '24	Buy	0.55	92,600	50,930	870,058	Mar 25 08:30 AM
Cook Patrick	Chief Commercial Officer	Mar 20 '24	Sale	0.53	48,911	25,923	1,245,205	Mar 22 06:00 PM
Cook Patrick	Chief Commercial Officer	Mar 21 '24	Sale	0.58	23,000	13,340	1,222,205	Mar 22 06:00 PM
Mullings Tamara	Director	Mar 20 '24	Sale	0.55	25,442	13,993	229,087	Mar 22 06:00 PM
Chatila Ahmad R	Director	Mar 20 '24	Buy	0.54	92,500	49,950	777,458	Mar 21 08:30 AM
Chatila Ahmad R	Director	Mar 18 '24	Buy	0.49	101,800	49,882	684,958	Mar 19 08:30 AM
Morris Robert Phelps	Former Chief Financial Officer	Dec 13 '23	Sale	0.73	19,791	14,447	173,244	Dec 15 06:30 PM
Chatila Ahmad R	Director	Dec 08 '23	Buy	0.75	13,960	10,470	583,158	Dec 11 07:55 AM
Chatila Ahmad R	Director	Dec 01 '23	Buy	0.68	14,550	9,894	569,198	Dec 04 07:55 AM
SADASIVAM SHAKER	Director	Nov 17 '23	Buy	0.51	59,800	30,498	363,927	Nov 21 08:30 AM
PRIDDY WILLIAM A	Director	Nov 17 '23	Buy	0.52	20,000	10,400	377,032	Nov 20 07:55 AM
Behnen Cathy	CHIEF FINANCIAL OFFICER	Nov 15 '23	Buy	0.52	100,000	52,000	351,989	Nov 17 08:30 AM
Chatila Ahmad R	Director	Nov 14 '23	Buy	0.47	213,030	100,124	554,648	Nov 15 08:30 AM

RANI

Rani Therapeutics Holdings Inc

FTCI

FTC Solar Inc

Upgrade your FINVIZ experience